Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43.4M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
12.8M
-
Shares change
-
-1.29M
-
Total reported value, excl. options
-
$28.6M
-
Value change
-
-$2.98M
-
Put/Call ratio
-
0
-
Number of buys
-
15
-
Number of sells
-
-40
-
Price
-
$2.23
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q3 2022
74 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q3 2022.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.8M shares
of 43.4M outstanding shares and own 29.43% of the company stock.
Largest 10 shareholders include Prosight Management, LP (1.55M shares), VANGUARD GROUP INC (1.52M shares), Slate Path Capital LP (1.48M shares), SANDERS MORRIS HARRIS LLC (848K shares), BlackRock Inc. (779K shares), Bleichroeder LP (555K shares), CARLSON CAPITAL L P (535K shares), Robertson Stephens Wealth Management, LLC (479K shares), Monaco Asset Management SAM (459K shares), and DIMENSIONAL FUND ADVISORS LP (454K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.